Cytogam

DRUG3 trials

Sponsors

Johns Hopkins University, Fernanda P Silveira, MD, MS, University of Minnesota

Conditions

CMVCytomegalovirus (CMV) InfectionKidney Failure, ChronicKidney Transplant; Complications

Phase 1

CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients

RecruitingNCT07096453

University of MinnesotaCMV, Kidney Transplant; Complications

Start: 2025-10-02End: 2027-08-31Target: 30Updated: 2025-10-31

Phase 3

Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch

CompletedNCT00275509

Johns Hopkins UniversityKidney Failure, Chronic

Start: 2007-01-31End: 2010-06-30Updated: 2018-01-18

Phase 4

CytoGam for CMV Infection or Disease in Solid Organ Transplant Recipients

Enrolling by invitationNCT07009548

Fernanda P Silveira, MD, MSCytomegalovirus (CMV) Infection

Start: 2025-06-26End: 2027-12-01Target: 45Updated: 2026-08-10